Adverse events
| Ondansetron (n = 18) | Placebo (n = 18) | |
|---|---|---|
| There were no significant changes in laboratory parameters during the study, and in particular no increases in liver enzymes (alanine aminotransferase (ALT)). | ||
| Constipation | 7 | 6 |
| Required laxative | 3 | 1 |
| Headache | 1 | 1 |
| ALT (d0/d60) | 72.8 (58.0)/61.6 (56.3) | 64.5 (50.9)/68.0 (64.0) |